LIV 002
Alternative Names: LIV-002Latest Information Update: 05 Jan 2023
At a glance
- Originator Medytox
- Developer Liveome
- Class Antineoplastics; Bacteria
- Mechanism of Action Bacteria replacements; Microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Solid tumours